6 completed, 5 unknown, 4 terminated, 3 recruiting. 12 Not applicable, 3 Phase 2, 1 Phase 1, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 12 | Unknown 4, Completed 2, Not yet recruiting 2, Recruiting 2, Terminated 2 |
| Phase 2 | 3 | Completed 2, Recruiting 1 |
| Phase 1 | 1 | Terminated 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Alcohol Addiction: new trials by email Literature Review of Alcohol Addiction trials Research Report on Alcohol Addiction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| QAIAx - SGI/SI Smart Health Cities: Microcity Enclave Program (Quantum SI/AGI Agency a/k/a AI City Hall Project - UPSTO App Nos. 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428, 64/125,360; USPTO EO 9424 Assignment ID: 2101042 / ARN: REEL/FRAME: 76481/0026 - OUSD-R&E, Department of War) AI City Hall Project (AIhealth4u - Public Health Central), AI City Hall Project (QAIAx Microcity A - AI Public Health Central) - Asperger's Disorder, Asperger Disorder | Not applicable | Not yet recruiting | Veterans Recovery Network Inc. | 1000000 | 2026-10-01 | 2026-10-29 |
| Techniques for Activating Consciousness (TAC) for Outpatients With Moderate to Severe Alcohol Addiction TAC intervention - Alcohol Addiction | Not applicable | Not yet recruiting | Versailles Hospital | 98 | 2026-04-15 | 2026-04-16 |
| Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment and Reduction of Heavy Drinking in Individuals With of Alcohol Use Disorder (AUD) Deep TMS (DTMS), Sham (No Treatment) - Alcohol Use Disorder, Alcoholism | Not applicable | Recruiting | Brainsway | 186 | 2025-11-07 | 2026-10-27 |
| A Trial to Investigate the Effects of Cannabidiol Plus Naltrexone on Alcohol Craving in Patients With Alcohol Dependence Cannabidiol capsules, Naltrexone (drug), Placebo - Alcohol Addiction, Alcoholism | Phase 2 | Recruiting | Central Institute of Mental Health, Mannheim | 150 | 2025-07-22 | 2026-02-03 |
| Effects of Frontopolar TMS in Alcohol Craving Transcranial Magnetic Stimulation (TMS) - Alcohol Addiction | Not applicable | Recruiting | Goethe University | 34 | 2025-05-16 | 2026-01-22 |
| Epidemiological Study on the Prevalence of Mental Disorders in Slovakia Depression Disorders, Bipolar Affective Disorder | Completed | Comenius University | 3100 | 2025-02-13 | 2026-02-18 | |
| Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity? Semaglutide Injectable Product, Placebo - Alcohol Abuse, Alcohol Addiction | Phase 2 | Completed | Psychiatric Centre Rigshospitalet | 108 | 2023-06-13 | 2025-08-05 |
| Oxytocin and Naltrexone: Investigation of Combined Effects on Stress- and Alcohol Cue-induced Craving in Alcohol Use Disorder Oxytocin nasal spray, Naltrexone Pill, Placebo - Alcohol Use Disorder, Alcoholism | Phase 2 / Phase 3 | Completed | Central Institute of Mental Health, Mannheim | 62 | 2021-12-02 | 2024-03-29 |
| sTMS for Substance Use-disordered Veterans sTMS, sham sTMS - Cocaine Addiction, Opioid Addiction | Not applicable | Completed | VA Office of Research and Development | 42 | 2021-09-07 | 2024-01-17 |
| Qi Gong as a Method of Craving Reduction in Severe Addict Patients Qi Gong sessions - Alcohol Addiction, Alcohol Dependence | Not applicable | Unknown | Assistance Publique - Hôpitaux de Paris | 186 | 2018-10-04 | 2019-07-17 |
| Soberlink - MAP Outcomes Study Protocol Soberlink Cellular Device - Alcohol Addiction | Terminated | Soberlink Healthcare LLC | 6 | 2017-08-22 | 2018-05-15 | |
| Effect of N-acetylcysteine on Alcohol and Cocaine Use Disorders: A Double-Blind Randomized Controlled Trial. Alcohol N-acetylcysteine, Alcohol Placebo, Cocaine N-acetylcysteine - Cocaine Addiction, Alcohol Addiction | Phase 4 | Unknown | Hospital de Clinicas de Porto Alegre | 100 | 2017-01-01 | 2017-01-24 |
| Repetitive Transcranial Magnetic Stimulation (rTMS) of the Insula for Treatment of Alcohol Addiction rTMS 10 Hz targeting the insula, Sham rTMS - Alcohol Addiction | Not applicable | Unknown | Linkoeping University | 84 | 2015-11-01 | 2015-12-31 |
| Testing Interventions to Reduce Alcohol Consumption Among Outpatients in a Dental Setting Drinksmeter, Brief Advice of Alcohol Use - Alcohol Addiction, Mouth Diseases | Not applicable | Terminated | King's College Hospital NHS Trust | 10 | 2014-10-01 | 2019-09-11 |
| Transcranial Magnetic Stimulation in the Treatment of Addiction Verum rTMS, Sham rTMS - Alcohol Addiction | Not applicable | Unknown | IrisZorg | 30 | 2014-05-01 | 2013-10-31 |
| Internet-Based Relapse Prevention vs Face to Face Therapy at an Employee Assistance Program eChange, Face-to-face therapy - Alcohol Abuse, Alcohol Addiction | Not applicable | Terminated | Karolinska Institutet | 1 | 2014-01-01 | 2016-03-15 |
| Effectiveness of a Hospital Addiction Service in Treating Opioid and Alcohol Addiction Delayed Intervention (DI), Rapid Intervention (RI) - Alcohol Addiction, Opiate Addiction | Not applicable | Unknown | Women's College Hospital | 124 | 2013-09-01 | 2014-12-11 |
| Disulfiram as a Modulator of Amyloid Precursor Protein-processing Disulfiram - Alcohol Addiction | Completed | Johannes Gutenberg University Mainz | 17 | 2013-05-01 | 2017-07-24 | |
| Guided and Unguided Internet Treatment for Problematic Alcohol Use Choice, Messages, Self help - Alcohol Abuse, Alcohol Addiction | Not applicable | Completed | Karolinska Institutet | 80 | 2012-12-01 | 2015-09-02 |
| Study of the Opioid Modulation of the Effect of Alcohol on the Dopaminergic Reward System Placebo, Naltrexone - Alcohol Addiction | Phase 1 | Terminated | RWTH Aachen University | 43 | 2011-08-30 | 2019-09-12 |
Alcoholism (20) · Behavior, Addictive (3) · Cocaine-Related Disorders (3) · Opioid-Related Disorders (3) · Substance-Related Disorders (2) · Agoraphobia (1) · Alzheimer Disease (1) · Alzheimer Disease 10 (1) · Anorexia Nervosa (1) · Asperger Syndrome (1) · Attention Deficit Disorder with Hyperactivity (1) · Autistic Disorder (1) · Bipolar Disorder (1) · Bulimia Nervosa (1) · Coitus (1)
Alcohol-Related Disorders (20) · Chemically-Induced Disorders (20) · Mental Disorders (19) · Substance-Related Disorders (18) · Behavior (4) · Compulsive Behavior (3) · Impulsive Behavior (3) · Narcotic-Related Disorders (2) · Anxiety Disorders (1) · Attention Deficit and Disruptive Behavior Disorders (1) · Autism Spectrum Disorder (1) · Bipolar and Related Disorders (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Child Development Disorders, Pervasive (1)
Naltrexone (3) · Ethanol (2) · Cannabidiol (1) · Disulfiram (1) · Pharmaceutical Preparations (1) · Sodium Chloride (1) · Transcranial Magnetic Stimulation (1) · semaglutide (1)
Central Institute of Mental Health, Mannheim (2) · Karolinska Institutet (2) · Assistance Publique - Hôpitaux de Paris (1) · Brainsway (1) · Comenius University (1) · Goethe University (1) · Hospital de Clinicas de Porto Alegre (1) · IrisZorg (1) · Johannes Gutenberg University Mainz (1) · King's College Hospital NHS Trust (1) · Linkoeping University (1) · Psychiatric Centre Rigshospitalet (1) · RWTH Aachen University (1) · Soberlink Healthcare LLC (1) · VA Office of Research and Development (1)
Germany (4) · Sweden (4) · United States (4) · France (2) · Brazil (1) · Canada (1) · Denmark (1) · Israel (1) · Netherlands (1) · Slovakia (1) · United Kingdom (1)
Anne H Berman, PhD (2) · Alexandra Brazinova, prof. MD PhD (1) · Anders Fink-Jensen, MD, DMSc (1) · Anita Srivastava, MD MSc CCFP (1) · Flavio Pechansky, PhD (1) · John E McGeary, PhD (1) · Jonathan Repple, Prof. Dr. (1) · Kristina Endres (1) · Leslie Buckley, MD, MPH (1) · Lisia von Diemen, PhD (1) · Maarten Belgers, MD (1) · Marek Majdan, prof. MS PhD (1) · Maren Schmidt-Kassow, Prof. Dr. (1) · Maria Kralova, assoc.prof. MD PhD (1)
PMID 27383389, PMID 34034821, PMID 35285015, PMID 35410938, PMID 36717148, PMID 39779270, PMID 40123107, PMID 40803733, PMID 41253702, PMID 42070571